AB SCIEX acquires mass spectrometry business of Labindia Instruments

NewsGuard 100/100 Score

AB SCIEX, a global leader in life science analytical technologies, today announced that it has acquired the mass spectrometry business of Labindia Instruments Pvt. Ltd., a leading life science solutions service provider in India. This acquisition represents AB SCIEX's increasing investment in India, combining its global resources, world-class scientific expertise and product development leadership with well-established, local expertise and on-site support to advance science and respond to the growing needs of India's scientific community.

“Expansion of AB SCIEX's commercial operations in India will strengthen our position and help us build on the success of Labindia's mass spectrometry business as well as execute on our growth strategy”

Labindia's mass spectrometry business has been serving Indian users of AB SCIEX instrumentation for the past 15 years. The transition of this business, including customer relationships, personnel and application support facilities, to AB SCIEX is a direct result of the successful track record that AB SCIEX and Labindia have had as partners in India. AB SCIEX's expansion of its commercial operations in India is expected to create new opportunities for customer interactions, collaborations and innovation.

AB SCIEX has a more than 20-year history of innovation and is a market leader in mass spectrometry, which is a workhorse analytical technique for a wide variety of scientific applications, including food contamination testing, environmental analysis, biomedical research, drug discovery and development, forensic toxicology and vitamin D analysis, among other emerging applications in clinical research.

The company has been actively involved in applying the power of mass spectrometry to assist in efforts to protect the health and safety of India's vast population. AB SCIEX announced last year, for instance, that through its distribution relationship with Labindia, it supplied a food safety testing solution to six major laboratories under the pesticides monitoring network project by India's government. This was part of a project with the Ministry of Agriculture to help reinforce new food safety standards through better monitoring for contamination.

"Expansion of AB SCIEX's commercial operations in India will strengthen our position and help us build on the success of Labindia's mass spectrometry business as well as execute on our growth strategy," said Umesh Pawa, Managing Director, AB SCIEX India. "By integrating Indian sales, service and support functions into AB SCIEX's global resources and operational excellence, we will simplify the process for customers to do business with AB SCIEX and drive the highest standard of support, further enhancing customer satisfaction levels. We will now be able to engage in a new level of dialogue with Indian scientists, who are among the leaders pushing the limits to improve life in this region."

AB SCIEX and Labindia are working closely to ensure a smooth transition of Labindia's former mass spectrometry-focused personnel, who will provide uninterrupted service and support during this changeover and continue to be the day-to-day contacts for Indian mass spectrometry customers. As part of AB SCIEX, the team will continue to work from their current locations in India.

Source:

 AB SCIEX

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A high-protein diet and elevation in the amino acid leucine may contribute to buildup of plaque in arteries